Authors
Latest:
Next-gen lasers and IOLs for every patient: the year ahead in corneaWhy “acceleration” is the industry keyword for 2024
Latest:
Sustained-release anti-inflammatory therapy proves valuable in NIULong-term treatment helps chronic, vision-threatening disease.
Latest:
Treating anisometropic amblyopia with a dichoptic digital platformThe investigators found that the corrected distance visual acuity (CDVA) in the amblyopic eye improved significantly in all patients regardless of age
Latest:
Insights into the future of eye careA UK health data research hub containing vast numbers of fundus and OCT images opens the door to improved screening and diagnoses of eye diseases and even ‘oculomic’ services for systemic health.
Latest:
Assessing the quality of real-world evidence in retinal diseasesA recently developed tool can help ophthalmologists to assess the quality of findings from real-world studies in retinal diseases. This will help them decide which results are most robust and applicable to their practice.
Latest:
ASRS 2024: Long-term results of macular hole surgery with long-acting gas tamponadeJohn Thompson, MD, discusses long-term results of using ICG to peel ILM in the treatment of macular holes
Latest:
Assessing the quality of real-world evidence in retinal diseasesA recently developed tool can help ophthalmologists to assess the quality of findings from real-world studies in retinal diseases. This will help them decide which results are most robust and applicable to their practice.
Latest:
Pearls for management of Pseudomonas scleritisDr Zeba A. Syed emphasises the importance of performing surgery sooner rather than later for patients with Pseudomonas scleritis
Latest:
New goniotomy device + careful post-op care limits intraoperative bleedingA new device for goniotomy has the advantage of an irrigation/aspiration system, which offers easier excision of the trabecular meshwork and better visibility. Dr Desai shares his experiences using the device as well as his tips and surgical pearls for success.
Latest:
Worldwide pathological myopia discussed by panel at EURETINA 2021Dr Ramin Tadayoni discusses the myopia panel at the EURETINA 2021 virtual meeting.
Latest:
Artificial DMEK could help tackle endothelial donor tissue shortageNewly developed acrylic implant provides option for patients with endothelial dysfunction.
Latest:
Global partnership targets ROP in premature infantsAn AI-supported telemedicine effort from Siloam Vision and Orbis International
Latest:
New options are on the horizon for presbyopia-correcting dropsFor ophthalmologists, finding the ideal solution for presbyopia has long been the ‘holy grail’ of the field.
Latest:
Harnessing digital media for enhanced patient engagement and outcomesPatients who received digital education demonstrated a better understanding of their disease and its management
Latest:
Using pivotal study data to guide glaucoma patient management decisionsTwo randomised controlled trials, EMGT and UKGTS, have examined the factors affecting the risk of glaucoma progression. Global target IOPs are not the best option for all patients.
Latest:
Digital visual training helps treat disorders associated with close workComputer software platform provides home vision exercises to overcome asthenopia.
Latest:
Letter to the Editor: Intravitreal injections. Who should perform them?In response to a previously published article, three ophthalmologists present their views on intravitreal pharmacotherapy injections.
Latest:
First-ever retinal gene therapy: Does real-world experience back its use?Recent reports of retinal atrophy have raised concerns on potential long-term safety.
Latest:
ASRS 2024: First-time results from a phase 1b study of FAS inhibition with ONL-1204Durga Borkar, MD, MMCi, discusses FAS inhibition with ONL-1204 for the treatment of geographic atrophy
Latest:
Focusing on functional vision with monofocal lensesQuantitative and qualitative improvement in IOL design
Latest:
Short-term corticosteroid use can provide rapid relief of allergy symptoms in dry eye diseaseA short course of a low-dose corticosteroid eye drop can relieve inflammation with only a low increase in intraocular pressure.
Latest:
Cross-linking in paediatric patients: The case for treating keratoconus without waiting for disease progressionThe case for treating keratoconus without waiting for disease progression
Latest:
TEASE-3 study: Positive interim data are reported for Stargardt drugGildeuretinol halts Stargardt disease progression, study results indicate
Latest:
Distorted corneas: How to regularise them with minimally invasive surgerySequential customised therapeutic keratectomy (SCTK) improves visual quality by eliminating superficial corneal high order aberrations
Latest:
Gene therapy research ushers in new therapy options for retinal diseasesFoundation Fighting Blindness is a driving force in advancing retinal gene therapies into clinical trials.
